4.6 Article

Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes

Journal

JOURNAL OF INORGANIC BIOCHEMISTRY
Volume 102, Issue 2, Pages 193-202

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jinorgbio.2007.07.035

Keywords

ruthenium complex; antitumor drug; DNA-binding; quantitative structure-activity relationship (QSAR)

Ask authors/readers for more resources

A series of octahedral Ru(II) polypyridyl complexes, [Ru(phen)(2)L](2+) (L = R-PIP and PIP = 2-phenylimidazo[4,5-f][1,10]phenanthroline) were synthesized and characterized by elementary analysis, H-1 NMR and ES-MS, as well as UV-visible spectra and emission spectra. The antitumor activities of these complexes and their corresponding ligands were investigated against mouse leukemia L1210 cells, human oral epidermoid carcinoma KB cells, human promyelocytic leukemia cells (HL-60) and Bel-7402 liver cancer cells by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. It was found that the complexes [Ru(phen)(2)L](2+) (L = R-PIP) exert rather potent activities against all of these cell lines, especially for the KB cells (IC50 = 4.7 +/- 1.3 mu M). The binding affinities of these Ru(II) complexes to CT-DNA (calf thymus DNA), as well as the DNA-unwinding properties on supercoiled pBR322 DNA were also investigated. The results showed that these Ru(II) polypyridyl complexes not only had an excellent DNA-binding property but also possessed a highly effective DNA-photocleavage ability. The structure-activity relationships and antitumor mechanism were also carefully discussed. (c) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available